AUTONOMIC DYSFUNCTION IN PATIENTS WITH HIV-INFECTION RECEIVING ANTIRETROVIRAL THERAPY: STUDY OF HEART RATE VARIABILITY
DOI:
https://doi.org/10.11603/1681-2727.2016.2.6517Keywords:
HIV-infection, heart rate variability, highly active antiretroviral therapy, molsydomin.Abstract
The dynamics of changes in time and spectral parameters of heart rate variability in 44 HIV-infected patients are analizyed in the article. The patients received highly active antiretroviral therapy and treatment, complete with nitric oxide donor – molsydomin. It is shown that the additional inclusion of molsydomin in treatment of HIV-infected patients helps to restore autonomic balance by reducing sympathicotonia.
References
Compostella C. Cardiovascular autonomic neuropathy in HIV-positive african patients / C. Compostella, L. Compostella, R. DElia // Minerva cardioangiologica. – 2008. – Vol. 56. – P. 417-428.
Power spectral analysis of heart rate variability in HIV-infected and AIDS patients / [D. Correia, D.E. Rodrigues, L.A. Resende et al.] // PACE. – 2006. – Vol. 29. – P. 53-58.
Autonomic dysfunction as a predictor of heart disease in human immunodeficiency virus (HIV) / [Y. Elnahar, M. Bisharat, J. Daoko et al.] // J. AIDS HIV Res. – 2013. – Vol. 5, N 1. – P. 1-11.
Heart rate variability and autonomic function tests in HIV positive individuals in India / [A. Sakhuja, A. Goyal, A.K. Jaryal et al.] // Clin. Auton. Res. – 2007. – Vol. 17, N 3. – P. 193-196.
Yun A.J. Modulation of host immunity by HIV may be partly achieved through usurping host autonomic functions / A.J. Yun, P.Y. Lee, K.A. Bazar // Med Hypotheses. – 2004. – Vol. 63. – P. 362-366.
Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia / [D.S. Chow, R. Wood, J. Choi et al.] // HIV Clin. Trials. – 2011. – Vol. 12, N 3. – P. 141-150.
Chimelli L. Degenerative and inflammatory lesions in sympathetic ganglia: further morphological evidence for an autonomic neuropathy in AIDS / L. Chimelli, A. R. Martins // J. NeuroAIDS. – 2002. – Vol. 2. – P. 67-82.
Zaporozhan V.M. VIL-infektsiia i SNID / V.M. Zaporozhan, M.L. Ariaiev. – K.: Zdorovia, 2004. – 636 s.
Malpas S.C. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease / S.C. Malpas // Physiol Rev. – 2010. – Vol. 90. – P. 513-517.
Ramchandra R. Nitric oxide and sympathetic nerve activity in the control of blood pressure / R. Ramchandra, C.J. Barret,
S.C. Malpas // Clin. Exp. Pharmacol. Physiol. – 2005. – Vol. 32,
N 5-6. – P. 440-446.
Prevalence of metabolic syndrome in HIV infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and adult treatment panel III criteria / [K. Samaras, H. Wand, M. Law et al.] // Diabetes Care. – 2007. – Vol. 30. – R. 113-119.
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection / [H. Wand, A. Calmy, D.L. Carey et al.] // AIDS. – 2007. – Vol. 21,
N 18. – R. 2445-2453.
Effects of HIV infection and antiretroviral therapy on the heart and vasculature / [M.P. Dubé, S.E. Lipshultz, C.J. Fichtenbaum et al.] // Circulation. – 2008. – Vol. 118. – R. e36-e40.
Starkova N.T. Metabolicheskij sindrom insulinorezistentnosti: osnovnaya koncepciya i sledstvie: obzor / N.T. Starkova, I.V. Dvoryashina // Terapevt. arkh. – 2004. – № 10. – S. 54-58.
Lechenie VICh-infekcii / [M. Al'tfel'd, G. Berens, P. Braun i dr.]; pod. red. K. KHoffman, Yu.K. Rokshtro. — M.: R. Valent, 2012. — 736 s..
Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol / [G. Askgaard, U.S. Kristoffersen, J. Mehlsen et al.]. // PLoS ONE. – 2011. – Vol. 6. – P. e20196.
Klinichnyi protokol antyretrovirusnoi terapii VIL-infektsii u doroslykh ta pidlitkiv. – Zatverdzheno nakazom MOZ Ukrainy № 551 vid 12.07.2010 r.: http://mozdocs.kiev.ua/view.php?id=11177.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use // Circulation. – 1996. – Vol. 93. – R. 1043-1065.
Zharinov O.I. Doslidzhennia variabelnosti rytmu sertsia: chy ziavliatsia novi uzghodzheni rekomendatsii? / O.I. Zharinov,
U.P. Cherniaha-Roiko // Ukr. kardiol. zhurn. – 2007. – № 6. – S. 98-102.
Bokeriya L.A. Variabel'nost' serdechnogo ritma: metody' izmereniya, interpretaciya, klinicheskoe ispol'zovanie / L.A. Bokeriya, O.L. Bokeriya, I.V. Volkovskaya // Annaly' aritmologii. – 2009. – № 4. – S. 21-32.
Yabluchanskij N.I. Variabel'nost' serdechnogo ritma v pomoshh' prakticheskomu vrachu / N.I. Yabluchanskij, A.V. Marty'nenko. – KHar'kov, 2010. – 131 s.
Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability / [A. Lebech, U.S. Kristoffersen, J. Mehlsen et al.] // Clin. Physiol. Funct. Imaging. – 2007. – Vol. 27. –
R. 363-367.
Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease? / [W.T. Cade, D.N. Reeds, S. Lassa-Claxton et al.]. // HIV Med. – 2008. – Vol. 9. – P. 96-100.
Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial / [E.Z. Soliman, M.P. Roediger, D.A. Duprez et al.] // BMJ Open. – 2013. – Vol. 3. –
P. e002523.
Heart rate variability in HIV patients, diabetics, and controls: The AGATAA Study / [I.M. Bensenor, M. Eira, E.L. Dorea et al.] // ISRN Vascular Medicine. – 2011. – Article ID 876864, 8 p.
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
